Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Blood Washing in Cardiac Surgery
NCT07212842Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in Systemic Inflammatory Response Syndrome (SIRS), Fluid overload, sponsored by Universidade de São Paulo. Started Apr 2021; status: completed.
02
Drugs
methylene blue
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)Fluid overload
Beyond the preview
Go deeper on NCT07212842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212842.